Preliminary evaluation of [¹⁸F]AlF-NOTA-MAL-Cys³⁹-exendin-4 in insulinoma with PET

References

• Ehehalt F, Saeger HD, Schmidt CM, Grutzmann R. Neuroendocrine tumors of the pancreas. Oncologist 2009;14:456–67
   PubMed Web of Science ®Google Scholar
• Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol 2013;19:829–37
   PubMed Web of Science ®Google Scholar
• Chatziioannou A, Kehagias D, Mourikis D, et al. Imaging and localization of pancreatic insulinomas. Clin Imaging 2001;25:275–83
   PubMed Web of Science ®Google Scholar
• Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab 2009;94:1069–73
   PubMed Web of Science ®Google Scholar
• Noldge G, Weber MA, Ritzel RA, et al. Invasive diagnostic procedures for insulinomas of the pancreas. Radiologe 2009;49:224–32
   PubMed Web of Science ®Google Scholar
• Guettier JM, Kam A, Chang R, et al. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. J Clin Endocrinol Metab 2009;94:1074–80
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen W. Radiolabeled glucagon-like peptide-1 analogues: a new pancreatic beta-cell imaging agent. Nucl Med Commun 2012;33:223–7
   PubMed Web of Science ®Google Scholar
• Brom M, Oyen WJ, Joosten L, et al 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Eur J Nucl Med Mol Imaging 2010;37:1345–55
   PubMed Web of Science ®Google Scholar
• Gao H, Niu G, Yang M, et al. PET of insulinoma using (1)(8)F-FBEM-EM3106B, a new GLP-1 analogue. Mol Pharm 2011;8:1775–82
   PubMed Web of Science ®Google Scholar
• Deacon CF, Johnsen AH, Holst JJ. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 1995;80:952–7
   PubMed Web of Science ®Google Scholar
• Islam D, Zhang N, Wang P, et al. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. Am J Physiol Endocrinol Metab 2009;296:E174–81
   PubMed Web of Science ®Google Scholar
• Eng J, Kleinman WA, Singh L, et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 1992;267:7402–5
   PubMed Web of Science ®Google Scholar
• Wild D, Behe M, Wicki A, et al. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. J Nucl Med 2006;47:2025–33
   PubMed Web of Science ®Google Scholar
• Christ E, Wild D, Forrer F, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab 2009;94:4398–405
   PubMed Web of Science ®Google Scholar
• Wild D, Wicki A, Mansi R, et al. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med 2010;51:1059–67
   PubMed Web of Science ®Google Scholar
• Sowa-Staszczak A, Pach D, Mikolajczak R, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging 2013;40:524–31
   PubMed Web of Science ®Google Scholar
• Wu Z, Todorov I, Li L, et al. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor. Bioconjug Chem 2011;22:1587–94
   PubMed Web of Science ®Google Scholar
• Mikkola K, Yim CB, Fagerholm V, et al. 64Cu- and 68Ga-labelled [Nle(14),Lys(40)(Ahx-NODAGA)NH2]-exendin-4 for pancreatic beta cell imaging in rats. Mol Imaging Biol 2014;16:255–63
   PubMed Web of Science ®Google Scholar
• Yue X, Kiesewetter DO, Guo J, et al. Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas. Bioconjug Chem 2013;24:1191–200
   PubMed Web of Science ®Google Scholar
• Kiesewetter DO, Gao H, Ma Y, et al. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma. Eur J Nucl Med Mol Imaging 2012;39:463–73
   PubMed Web of Science ®Google Scholar
• Kiesewetter DO, Guo N, Guo J, et al. Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma. Theranostics 2012;2:999–1009
   Google Scholar
• Wu Z, Liu S, Hassink M, et al. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med 2013;54:244–51
   PubMed Web of Science ®Google Scholar
• Doyle ME, Theodorakis MJ, Holloway HW, et al. The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity. Regul Pept 2003;114:153–8
   PubMed Web of Science ®Google Scholar
• Xu Y, Pan D, Xu Q, et al. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe 18F-FBEM-Cys39-exendin-4. J Cancer Res Clin Oncol 2014;140:1479–88
   PubMed Web of Science ®Google Scholar
• Xu Y, Pan D, Zhu C, et al. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging. Mol Imaging Biol 2014;16:578–85
   PubMed Web of Science ®Google Scholar
• Lang L, Li W, Guo N, et al. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjug Chem 2011;22:2415–22
   PubMed Web of Science ®Google Scholar
• Liu Z, Niu G, Wang F, Chen X 68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. Eur J Nuclear Med Mol Imaging 2009;36:1483–94
   PubMed Web of Science ®Google Scholar
• Wan W, Guo N, Pan D, et al. First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J Nucl Med 2013;54:691–8
   PubMed Web of Science ®Google Scholar
• Pan D, Yan Y, Yang R, et al. PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN. Contrast Media Mol Imaging 2014;9:342–8
   PubMed Web of Science ®Google Scholar
• McBride WJ, Sharkey RM, Karacay H, et al. A novel method of 18F radiolabeling for PET. J Nucl Med 2009;50:991–8
   PubMed Web of Science ®Google Scholar
• Vegt E, Eek A, Oyen WJ, et al. Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides. Eur J Nucl Med Mol Imaging 2010;37:226–34
   PubMed Web of Science ®Google Scholar